← Open Payments lookup

AMY ASHLEY: Open Payments

NPI 1518730449 · OZARK, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,099 in 126 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $773 · 2025 $2,099

Food & beverage: $2,099
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$384
E.R. Squibb & Sons, L.L.C.29$333
Otsuka America Pharmaceutical, Inc.12$319
ABBVIE INC.22$302
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$179
Teva Pharmaceuticals USA, Inc.13$157
Janssen Pharmaceuticals, Inc4$92
Alkermes, Inc.5$83
Axsome Therapeutics, Inc.3$68
Lundbeck LLC4$66

Products named: INGREZZA, COBENFY, VRAYLAR, REXULTI, CAPLYTA, UZEDY, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across MO — which companies pay providers there.